LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

Home・Akcijų sąrašas・Evolent Health Inc

Evolent Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

4.12 5.1

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

4.01

Max

4.12

Pagrindiniai rodikliai
By Trading Economics
Pajamos	30M -21M
Pardavimai	35M 480M
Pelno marža	-4.351
Darbuotojai	4,500
EBITDA	512K 15M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+157.36% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-324M 456M
Ankstesnė atidarymo kaina	-0.98
Ankstesnė uždarymo kaina	4.12

Naujienos nuotaikos

By Acuity

72%

28%

333 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

10.33 / 10.95 Palaikymas ir pasipriešinimas

Evolent Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-12 16:42; UTC

Įsigijimai, susijungimai, perėmimai

FTC Sues to Block Henkel's $725 Million Deal for Liquid Nails From PE Firm -- 2nd Update

2025-12-12 23:49; UTC

Įsigijimai, susijungimai, perėmimai

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

2025-12-12 22:52; UTC

Rinkos pokalbiai

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

2025-12-12 22:32; UTC

Uždarbis

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

2025-12-12 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-12 20:45; UTC

Uždarbis

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

2025-12-12 20:41; UTC

Rinkos pokalbiai

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

2025-12-12 20:20; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

2025-12-12 19:23; UTC

Uždarbis

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

2025-12-12 18:35; UTC

Įsigijimai, susijungimai, perėmimai

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

2025-12-12 18:33; UTC

Įsigijimai, susijungimai, perėmimai

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

2025-12-12 18:31; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

2025-12-12 17:49; UTC

Uždarbis

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

2025-12-12 17:34; UTC

Įsigijimai, susijungimai, perėmimai

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

2025-12-12 17:33; UTC

Įsigijimai, susijungimai, perėmimai

Orange: Closing of the Transaction Is Expected in the First Half of 2026

2025-12-12 17:33; UTC

Įsigijimai, susijungimai, perėmimai

Orange: Agreement Confirms the Non-Binding Agreement That Was Previously Announced Oct. 31

2025-12-12 17:32; UTC

Įsigijimai, susijungimai, perėmimai

Orange: MasOrange Is Spain's Leading Operator in Terms of Customer Base

2025-12-12 17:31; UTC

Įsigijimai, susijungimai, perėmimai

Orange to Buy the Stake for EU4.25B in Cash

2025-12-12 17:24; UTC

Rinkos pokalbiai

Argentina Predicts Record Wheat Crop -- Market Talk

2025-12-12 17:20; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-12-12 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-12 17:18; UTC

Rinkos pokalbiai

Uždarbis

Broadcom, Oracle Investor Reactions Show High Bar for AI Cos. -- Market Talk

2025-12-12 17:09; UTC

Rinkos pokalbiai

Broadcom Investors Were Primed to Sell Shares -- Market Talk

2025-12-12 17:09; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-12-12 16:47; UTC

Rinkos pokalbiai

Broadcom's Margins Expected to Narrow Due to AI Revenue -- Market Talk

2025-12-12 16:39; UTC

Rinkos pokalbiai

Supply Limits, Geopolitical Risk to Support Crude in 2026 -- Market Talk

2025-12-12 16:27; UTC

Įsigijimai, susijungimai, perėmimai

FTC Sues to Block Henkel's $725M Deal for Liquid Nails From PE Firm -- 2nd Update

2025-12-12 16:15; UTC

Uždarbis

At Costco, Lots of Pie but No Special Dividend. Why the Street Didn't Like the Earnings. -- Barrons.com

2025-12-12 15:35; UTC

Uždarbis

These Stocks Are Moving the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

2025-12-12 14:46; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Evolent Health Inc Prognozė

Kainos tikslas

By TipRanks

157.36% į viršų

12 mėnesių prognozė

Vidutinis 10.14 USD 157.36%

Aukščiausias 16 USD

Žemiausias 7 USD

Remiantis 13 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Evolent Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

13 ratings

Pirkti

Laikyti

Parduoti

Remiantis 13 analitikų, pateikusių Evolent Health Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

10.33 / 10.95Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Rinkos nuotaikos

By Acuity

333 / 374 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.